Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Status:
Completed
Trial end date:
2018-05-15
Target enrollment:
Participant gender:
Summary
This trial is conducted globally. The aim of this trial is to investigate efficacy and safety
of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal
impairment.